Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Lunit Inc. (328130.KQ)
KRW11,070.00
-50.00 (-0.45%)
KR KOE Technology Software - Application
Address
K-Square Gangnam 2
Seoul, KR
Seoul, KR
CEO
Beomseok Brandon Suh
Website
lunit.io
IPO
2022-07-21
ISIN KR7328130000
Description
Lunit Inc., established in 2013 and headquartered in Seoul, South Korea, develops and supplies advanced artificial intelligence software solutions aimed at improving cancer screening, diagnosis, and treatment. The company's portfolio includes AI-powered tools for analyzing medical images like chest X-rays and mammograms, as well as intelligent biomarkers for immune phenotyping and precise PD-L1 quantification, which are vital for optimizing immunotherapy.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW11,070.00
-50.00 (-0.45%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
476.9K
Beta
1.12
Float Shares
50.91M
Free Float %
87.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.60% | -7.45% | -19.13% | -11.93% | -16.30% | -23.73% | -29.65% | -18.74% | +67.60% | +67.60% | +67.60% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
11,070.00
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.08
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Software - Application: +12.6%+53.4% ★ Q1'26: +24.7% (vs Q1'25)
-
EPS growth Software - Application: +31.4%+60.0% ★ Q1'26: -968.9% (vs Q1'25)
-
FCF margin Software - Application: +41.0%-99.9% Q1'26: -38.5% (vs Q1'25)
-
EBIT margin Software - Application: +8.5%-100.0% Q1'26: -56.8% (vs Q1'25)
-
ROIC Software - Application: +6.4%— Q1'26: -23.5% (vs Q1'25)
-
Share dilution Software - Application: +0.0%+41.3% Q1'26: +1.1% (vs Q1'25)
-
Debt / EBITDA Software - Application: -0.78×0.00× ★ Q1'26: -3.39× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
25.08B
est: 24.93B (+0.6%)
|
54.18B
est: 54.67B (-0.9%)
|
83.13B
est: 78.81B (+5.5%)
|
102.37B
102.37B – 102.37B
+29.9% YoY
|
123.29B
123.29B – 123.29B
+20.4% YoY
|
128.84B
128.84B – 128.84B
+4.5% YoY
|
| EBITDA |
-30.98B
est: -24.31B (-27.4%)
|
-61.83B
est: -53.31B (-16.0%)
|
-72.80B
est: -76.85B (+5.3%)
|
-99.83B
-99.83B – -99.83B
-29.9% YoY
|
-120.22B
-120.22B – -120.22B
-20.4% YoY
|
-125.63B
-125.63B – -125.63B
-4.5% YoY
|
| EBIT |
-34.75B
est: -24.93B (-39.4%)
|
-69.53B
est: -54.67B (-27.2%)
|
-83.09B
est: -78.80B (-5.4%)
|
-102.37B
-102.37B – -102.37B
-29.9% YoY
|
-123.29B
-123.29B – -123.29B
-20.4% YoY
|
-128.83B
-128.83B – -128.83B
-4.5% YoY
|
| Net Income |
-36.80B
est: -49.20B (+25.2%)
|
-82.42B
est: -30.06B (-174.2%)
|
-46.63B
est: -19.76B (-136.0%)
|
-55.29B
-55.29B – -55.29B
-179.9% YoY
|
-34.76B
-34.76B – -34.76B
+37.1% YoY
|
-38.36B
-38.36B – -38.36B
-10.3% YoY
|
| SGA |
14.50B
est: 14.43B (+0.5%)
|
26.37B
est: 31.64B (-16.6%)
|
—
est: 45.61B (-100.0%)
|
59.25B
59.25B – 59.25B
+29.9% YoY
|
71.35B
71.35B – 71.35B
+20.4% YoY
|
74.56B
74.56B – 74.56B
+4.5% YoY
|
| EPS |
-715.50
est: -758.19 (+5.6%)
|
-1,425.93
est: -463.19 (-207.8%)
|
-798.81
est: -304.45 (-162.4%)
|
-852.01
-852.01 – -852.01
-179.9% YoY
|
-535.68
-535.68 – -535.68
+37.1% YoY
|
-591.06
-591.06 – -591.06
-10.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-10 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-09 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-47.97B
OE per share TTM
-780.27
Owner's Yield
-4.89%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
54.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-240.85M
Shares Outstanding
58.32M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anthony S. Paek | Co-Founder & Executive Chairman | — | male |
| Beomseok Brandon Suh | CEO & Director | — | male |
| Donggeun Yoo | Co-founder, Chief AI Officer of Technology Innovation Group | — | male |
| Frederik Winther Struve | General Counsel - Lunit International | — | male |
| Hyeonseong Park | Chief Financial Officer | — | male |
| Jinsub Bae | Dept. Head of Finance & Accounting | — | male |
| Jungin Lee | Co-Founder & Dept Head of Infrastructure of Technology Innovation Group | — | male |
| Koren Cryer | Dept. Head of Marketing | — | female |
| Kyunghyun Paeng | Co-founder & Chief Product Officer of Oncology Group | — | male |
| Sunggyun Park | Co-founder and Chief Operating & Regulation Division Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 328130.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
